KFTA affirms new GMP policy will focus on guidance

The Korea Food and Drug Administration unveiled its plan to put more emphasis on guidance over the new good manufacturing practice and validation instead of administrative disposition.

In an information session on February 18, a KFDA official Sul Hyo-chan said the current GMP and validation system will be implemented with more flexibility to ensure that the pharmaceutical industry may be ada...